Genic Co. Ltd (123330) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.124x

Based on the latest financial reports, Genic Co. Ltd (123330) has a cash flow conversion efficiency ratio of -0.124x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-5.54 Billion ≈ $-3.75 Million USD) by net assets (₩44.56 Billion ≈ $30.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Genic Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.

Genic Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Genic Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Genic Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Genic Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genic Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Bassett Furniture Industries
NASDAQ:BSET
-0.145x
Tectonic Metals Inc
V:TECT
-0.483x
Decisive Dividend Corp
V:DE
0.050x
Fleetwood Ltd
AU:FWD
0.000x
Journey Medical Corp
NASDAQ:DERM
-0.200x
Tenaya Therapeutics Inc
NASDAQ:TNYA
-0.188x
SR Bancorp, Inc. Common stock
NASDAQ:SRBK
0.019x
Military Insurance Corp
VN:MIG
N/A

Annual Cash Flow Conversion Efficiency for Genic Co. Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Genic Co. Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Genic Co. Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩41.05 Billion
≈ $27.82 Million
₩20.65 Billion
≈ $13.99 Million
0.503x +3990.77%
2024-12-31 ₩22.15 Billion
≈ $15.01 Million
₩272.46 Million
≈ $184.64K
0.012x +152.86%
2023-12-31 ₩11.53 Billion
≈ $7.81 Million
₩-268.31 Million
≈ $-181.83K
-0.023x -308.47%
2022-12-31 ₩15.94 Billion
≈ $10.80 Million
₩177.94 Million
≈ $120.59K
0.011x -93.52%
2021-12-31 ₩19.30 Billion
≈ $13.08 Million
₩3.32 Billion
≈ $2.25 Million
0.172x +1708.60%
2020-12-31 ₩22.33 Billion
≈ $15.13 Million
₩212.66 Million
≈ $144.12K
0.010x -81.23%
2019-12-31 ₩27.14 Billion
≈ $18.39 Million
₩1.38 Billion
≈ $933.12K
0.051x +122.19%
2018-12-31 ₩38.94 Billion
≈ $26.39 Million
₩-8.90 Billion
≈ $-6.03 Million
-0.229x -203.64%
2017-12-31 ₩54.27 Billion
≈ $36.78 Million
₩-4.09 Billion
≈ $-2.77 Million
-0.075x -342.20%
2016-12-31 ₩61.93 Billion
≈ $41.97 Million
₩1.93 Billion
≈ $1.30 Million
0.031x -50.31%
2015-12-31 ₩58.04 Billion
≈ $39.33 Million
₩3.63 Billion
≈ $2.46 Million
0.063x -40.55%
2014-12-31 ₩55.16 Billion
≈ $37.38 Million
₩5.80 Billion
≈ $3.93 Million
0.105x +52.34%
2013-12-31 ₩53.25 Billion
≈ $36.08 Million
₩3.68 Billion
≈ $2.49 Million
0.069x -15.26%
2012-12-31 ₩52.87 Billion
≈ $35.83 Million
₩4.31 Billion
≈ $2.92 Million
0.082x --

About Genic Co. Ltd

KQ:123330 Korea Household & Personal Products
Market Cap
$136.81 Million
₩201.88 Billion KRW
Market Cap Rank
#17971 Global
#733 in Korea
Share Price
₩25800.00
Change (1 day)
-2.46%
52-Week Range
₩15920.00 - ₩39650.00
All Time High
₩42600.00
About

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more